HSCS (HeartSciences Inc. Common Stock) Stock Analysis - Insider Trades

HeartSciences Inc. Common Stock (HSCS) is a publicly traded Healthcare sector company. As of May 21, 2026, HSCS trades at $1.99 with a market cap of $5.92M and a P/E ratio of -0.40. HSCS moved +0.00% today. Year to date, HSCS is -37.34%; over the trailing twelve months it is -57.02%. Its 52-week range spans $1.77 to $6.47. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces HSCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading HSCS stock inside the company?

Recent HSCS insider activity includes HILZ MARK T sold 4.42K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

HSCS Key Metrics

Key financial metrics for HSCS
MetricValue
Price$1.99
Market Cap$5.92M
P/E Ratio-0.40
EPS$-4.61
Dividend Yield0.00%
52-Week High$6.47
52-Week Low$1.77
Volume145
Avg Volume0
Revenue (TTM)$8.67K
Net Income$-8.49M
Gross Margin57.92%

Recent HSCS Insider Trades

  • HILZ MARK T sold 4.42K (~$15.62K) on Jul 29, 2025.

Latest HSCS News

HSCS Analyst Consensus

2 analysts cover HSCS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.

Common questions about HSCS

Who is trading HSCS stock inside the company?
Recent HSCS insider activity includes HILZ MARK T sold 4.42K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for HSCS?
Yes. Rallies tracks HSCS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is HSCS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HSCS. It does not provide personalized investment advice.
HSCS

HSCS